Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Romagnoli M
Grupos
Abstract
Raynaud's phenomenon (RP) is an episodic peripheral circulatory disorder characterized by local artery spams in subjects exposed to cold or emotional stress. It is not well-established whether RP patients show an altered rheological profile, mostly due to patient classification and clinical severity. We aimed to compare the hemorheological profile in patients with primary and secondary RP with a healthy control group. Eighteen primary RP, 22 secondary RP and 22 healthy controls, were included in the study. RP patients were also divided according to the presence of digital ulcers (7 with, 33 without). Biochemical and hemorheological variables were analyzed, including glucose, triglycerides, total-cholesterol, immunoglobulins, fibrinogen, plasma viscosity, erythrocyte aggregation, erythrocyte deformability and blood viscosity. Age was higher in secondary RP as compared with primary (p=0.049), while glucose, triglycerides IgA, IgG and plasma viscosity were higher in secondary RP than in healthy subjects (p<0.05). RP patients with digital ulcers presented higher IgA (p=0.012), lower erythrocyte aggregation time (p=0.008) and a trend for higher fibrinogen levels and plasma viscosity (p=0.064, p=0.069, respectively). The results of the present study indicate that secondary RP patients show a mild impairment of the rheological profile that aggravates with microangiopathy severity.
Datos de la publicación
- ISSN/ISSNe:
- 1386-0291, 1875-8622
- Tipo:
- Article
- Páginas:
- 259-264
- DOI:
- 10.3233/CH-131723
- PubMed:
- 23609604
- Factor de Impacto:
- 0,810 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION IOS PRESS
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- Raynaud's phenomenon; hemorheology; digital ulcers
Proyectos y Estudios Clínicos
RED INVESTIGACION (RECAVA)
RD06/0014/0004 . INSTITUTO DE SALUD CARLOS III; FUNDACION PARA LA INV BIOMEDICA- HOSPITAL GREGORIO MARAÑON; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
RED CARDIOVASCULAR
Investigador Principal: FRANCISCO ESPAÑA FURIO
RD12/0042/0029 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
ENSAYO CLINICO FASE III, DE GRUPOS PARALELOS, RANDOMIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO Y MULTICENTRICO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACION DE TOCILIZUMAB EN PACIENTES DIAGNOSTICADOS DE ORBITOPATÍA TIROIDEA (OT) MODERADA A SE VERA O QUE AMENAZA LA VISTA, QUE NO HAN RESPONDIDO ADECUADAMENTE AL TRATAMIENTO CON PULSOS DE CORTICOIDES.
Investigador Principal: ENRIQUE ESPAÑA GREGORI
GRC-TCL-2010-01 . 2013
Cita
VAYÁ A,ALIS R,Romagnoli M,TODOLÍ J,CALVO J,RICART JM. Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy. Clin. Hemorheol. Microcirc. 2014. 56. (3):p. 259-264. IF:2,242. (3).